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Abstract 
Pregnancy is a physiological condition accompanied by a multitude of 
morphological, physiological and metabolic changes induced by the dynamic 
hormonal activity of the woman’s body. These changes are associated with an 
increased need for nutrient intake. The lack of proper nutrition or irrational 
use of dietary supplements may have deleterious effects on both the mother 
and the developing fetus. The optimized intake of microelements and vitamins 
could be beneficial and even prevent common pathological conditions which 
frequently occur during pregnancy. The aim of the current review is to 
evaluate the potential benefits and risks associated with the intake of food 
supplements during pregnancy. Relevant publications were searched and 
analyzed using the following data bases: MEDLINE/PubMed, Scopus, Web 
of Knowledge, and Internet. Numerous authors support the opinion that the 
lack of obligatory quality control of food supplements is associated with many 
low-quality products which could have harmful health effects. 
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Introduction 
Pregnancy is physiological condition associated with dynamic and 
anabolic processes and many physiologic adjustments that affect the 
metabolism of all nutrients. The main purpose of these adjustments is to 
support the fetal growth, the maternal homeostasis, and preparing the maternal 
organism for lactation (King 2000). 
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 Morphological and physiological characteristics of the pelvic organs 
during pregnancy 
The uterus is composed by three layers – endometrium, myometrium 
and serosa. The myometrium is mainly of smooth muscle tissue During 
pregnancy it undergoes hyperplasia and hypertrophy, greatly increasing its 
mass to accommodate the developing fetus. The cervix which connects the 
vaginal canal and the uterus is made up chiefly of collagen tissue. Unlike the 
myometrium, the cervix is much more denser and rigid which helps to support 
the expanding uterus. The lower segment of the uterus is formed by a junction 
called the isthmus. When cesarean section is performed, the incision is usually 
made through this particular area. The uterus is supplied with blood through 
the uterine arteries which branch out from the internal iliac arteries. They form 
a network in the uterine wall. Both sympathetic and parasympathetic 
innervation is present and it is often the subject of further studies as the finer 
functions of its motor pathways are yet to be fully clarified. It is known 
however that alpha-adrenergic receptor agonists stimulate the tissue of the 
myometrium whereas beta-adrenergic receptor agonists have inhibiting effect. 
Both pharmacological effects have been used in attempt to control premature 
labor. Through the pelvic splanchnic afferent fibers from the cervix enter the 
spinal cord at segments – S2,3,4. Nociception during labor is conveyed 
through the sympathetic plexus. The nerve fibers enter the spinal cord at the 
level of the thoracic segments (Magowan et al. 2009). 
 The cervix: Its morphological and physiological characteristics change 
throughout the stages of pregnancy 
In early pregnancy it is more vascular and less rigid. The secretions of 
the endocervical glands become more viscous and thicker. They serve as a 
barrier protecting the fetus from pathogens that may come from the vaginal 
canal. During the later stages of pregnancy, the cervix collagenous structure 
becomes much softer by absorbing polysaccharides (Magowan et al. 2009). 
 Changes in bones and joints 
These changes include the sacroiliac and symphyseal joints which 
become more extensible due to the action of the specific hormonal activity 
during pregnancy. This increased joint mobility facilitates labor but it may 
also be the cause for symphyseal pain. 
 Changes in metabolism 
There is an overall increased energy demand both for the fetus and the 
mother. This is followed by an increase of weight as the metabolic rate rises 
by an average of around 20 percent. Increased insulin sensitivity is also 
observed which in turn results in increased glycogen synthesis and 
accumulation of fat deposits and increased amino acid transfer in cells 
(Magowan et al. 2009). The overall morphological, physiological and 
metabolic changes which pregnant women undergo result in changes in blood 
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pressure, fluid retention, anemia, constipation, cholestasis. These however are 
considered beneficial for the fetus (Magowan et al. 2009). 
The mother’s metabolism during pregnancy adjusts to meet the needs of the 
progressively growing fetus and sustain its development. Glucose and amino 
acid transfer from the mother to the fetus is most abundant while lipid transfer 
is present at a much lesser degree but it is not less essential than the other main 
nutrients (Hod et al. 2008). Fetal growth and development also depend on 
other essential nutrients, like vitamins. Many studies have shown that the 
deficiency of micronutrients such as magnesium, zinc and iron is associated 
with abnormal fetal development and risk of miscarriage ( Mensah et al. 2018 
). However, the importance of vitamin deficiency has been somewhat 
overlooked as well as the importance of the antioxidant status of the mother 
and the fetus. Studies have found that these factors are equally essential for 
the proper fetal development as the optimal intake of microelements. The 
concentration of vitamins in the mother’s milk during breastfeeding is also 
dependent on their maternal serum levels. Other extra maternal factors include 
the consumption of constituents like phytanes and polyphenols which may 
inhibit the proper vitamin resorption. Even genetic polymorphism has been 
found to be a contributing factor (Hod et al. 2008). The importance of 
appropriate supplementation during pregnancy is undeniable, on the other 
hand recent studies have suggested that some food supplements could have a 
potential health risk (King 2003, Martello et al. 2007, Sanzini 2011). 
 
Materials and Methods 
Literature search was done using the following data bases: 
Medline/PubMed, Scopus, Web of Knowledge and Internet through the 
keywords “food supplements”, “dietary supplements”, “pregnancy”, “nutrient 
intake”, “maternal health”, “nutrients”, “fetal growth”. The present systematic 
review is based on a total of 61 publications satisfying the search criteria. Our 
study was limited to the most commonly used food supplements by pregnant 
women.  
 
Discussion 
I.  Benefits of food supplements during pregnancy 
1.  Folic acid 
Folic acid (fig. 1) is (2S)-2-[[4-[[(2-Amino-4-oxo-1,4-dihydropteridin-
6-yl)methyl]amino] benzoyl]amino] pentanedioic acid. The substance is 
yellowish or orange, crystalline powder (European Pharmacopoeia 7.0 2016). 
Folic acid is an essential nutrient. It is important for DNA replication. It is a 
substrate for many enzymatic reactions involved in amino acid synthesis and 
vitamin metabolism (Greenberg et al. 2011). One-carbon transfer reactions, 
including purine and thymidylate biosynthesis, amino acid metabolism and 
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formate oxidation are carried out with the presence of foliate (fig. 2). Purine 
and thymidylate biosynthesis are a fundamental requisite event underlying 
DNA and RNA synthesis (Hod et al. 2008). Demands for folate increase 
during pregnancy. It is important for growth and development of the fetus and 
for the maternal organism. The deficiency of folate is associated with 
abnormalities in maternal organism (anemia) and fetal development 
(Greenberg et al. 2011). The importance of the folic acid intake during/before 
pregnancy has been deeply discussed since 1960s (Hibbard 1964). The 
periconceptional intake of folic acid (400 μg daily) is associated with 
reduction in the risk of neural tube defects (Hibbard 1964; Shane 1995; Berry 
et al.1999). Figure 3 represents ultrasound picture of open spina bifida. In this 
condition, the spinal cord lies unprotected and exposed on the toxic effect of 
the amniotic fluid. These leads to damage of the spinal cord and the baby has 
problems with walking, passing urine and defecation. Open spina bifida is 
associated with central nerve system (CNS) abnormalities such as 
ventriculomegaly, hydrocephaly and “crush sign” at the back brain leading to 
additional damages. Additional intake should be at least one month prior to 
conception and should be continued throughout the first three months of 
pregnancy. Women who have had cases of previously affected children are 
recommended to take a higher dose of 4 mg per day. Additional folate can be 
acquired through various sources such as foods rich in folate like greens - 
broccoli, lettuce, etc. or by adding folic acid supplements to the diet. However, 
because dietary folate is less stable and has a lower bioavailability than 
supplementary folic acid, it is difficult to get enough folate from natural 
sources (Özek et al. 2008). Pregnant women who do not take extra folate 
supplements usually have decreased folate serum levels. This is due to a 
number of factors such as poor folate resorption, the increased folic needs of 
the fetus, increased catabolism, excretion and hormonal activity (Hod et al. 
2008). 
 
Figure.1 Structure of folic acid 
 
Folic acid                                Folinic acid                                                             DNA 
                                                 
                                                Enzyme acid                       Nucleotides 
                                                                                                                                 RNA 
                                        
                                                 Amino acids     
Figure 2. Importance of folic acid for DNA/RNA synthesis 
European Scientific Journal August 2019 edition Vol.15, No.24 ISSN: 1857 – 7881 (Print) e - ISSN 1857- 7431 
17 
 
Folate is essential for rapidly proliferating tissues such as newly 
formed bone tissue as it is necessary for nucleic acid biosynthesis. With the 
introduction of folic acid supplements, folate deficiency nowadays is less 
common that it was in the past. The risk of developing anemia and neural tube 
defects during pregnancy is significantly lower. However, studies have found 
that women who are more prone to folate dietary deficiency are less likely to 
include folate supplements during the course of pregnancy. For that reason, 
folate is usually prescribed by doctors in combination with iron to compensate 
for such deficiencies (Hanretty 2004). 
 
Figure 3. Ultrasound picture of open spina bifida – the surrounded area shows the defect of 
the spine and covering skin of the fetus. 
 
2.  Micronutrients 
Micronutrients, known also as vitamins and minerals, have a 
significant impact on the health status of pregnant woman and the developing 
fetus (Black 2001). The physiological needs for micronutrients increase during 
the period of lactation as opposed to those before pregnancy. The need for 
calcium, phosphorus and magnesium rises by 40-50 percent as well as those 
of folic acid. The combination of prenatal multivitamin supplements with the 
addition of extra folic acid is recommended during lactation as well as 
increased fluid intake to compensate for dehydration during breastfeeding. 
Changes in the diet may also be necessary. Dietary deficiencies including total 
protein, amino acids and B vitamins may be observed especially in individuals 
who practice veganism. In such individuals appropriate corrections to the 
dietary regime should be made to include extra quantities of protein, iron, 
vitamins B and D from vegan friendly sources like soya, nuts or other vegan 
combinations, while extra phytates and barn should be avoided (Gabbe et al. 
2002). In some diets high in unrefined grains and legumes, the amount of 
nutrients consumed may be adequate, but dietary constituents, such as 
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phytanes and polyphenols, can also limit their absorption. Here we summarize 
the main changes in the metabolism of the vitamins during pregnancy which 
are of major importance for the growth and development of the fetus (Hod et 
al. 2008). The deficiency of iron may have severely detrimental effects on both 
the fetus and the mother. Usually associated with anemia, iron deficiency, as 
well as folic acid deficiency, is also linked with an increased risk of 
hemorrhage during birth and congenital malformations in the fetus. Zinc 
deficiency may result in complications during pregnancy and delivery. Studies 
have found a connection between zinc deficiency and growth retardation, 
congenital abnormalities, delayed development of the immune and nervous 
systems of the fetus.  Deficiency of iodine during pregnancy is associated with 
cretinism, possible fetal loss and premature birth. The shortage of micro 
elements such as magnesium, selenium, copper and calcium, is also associated 
with complications in pregnancy, birth or development of the fetus. Vitamin 
A or beta-carotene supplements use during pregnancy has been found to 
reduce maternal mortality by 50 per cent in one controlled study (Black 2001). 
Deficiencies of vitamins other than folate are associated with fetal pathology. 
 
3.  Magnesium 
Magnesium is an essential microelement involved in many enzyme 
reactions (Makrides et al. 2014; Sanz 2011), acting as adenosine 
triphosphatase cofactor. It is crucial for energy-demanding metabolic 
processes as well as for protein synthesis and anaerobic phosphorylation. 
Magnesium homeostasis is maintained by the kidneys and small intestines. 
During conditions of magnesium shortage both organs increase the absorption 
of magnesium (Sanz 2011). Magnesium is involved in regulating body 
temperature, nucleic acid synthesis and protein metabolism. It also maintains 
the electrical potential of nerve and muscle cells. Pregnancy increases the need 
for magnesium however the majority of pregnant women rarely take action to 
compensate for those needs. Magnesium deficiency during pregnancy can be 
potentially detrimental to the health of both the mother and the fetus, with 
consequences that may affect the development of the child after birth (Lynne 
et al. 2016). Extra intake of magnesium during pregnancy shows significantly 
lower risk of maternal hospitalization, reduced risk of premature birth and 
lower need of intensive care for the newborn after birth (Spätling et al. 1988). 
Magnesium is necessary for the proper formation of bones and the various 
intracellular enzyme processes. Magnesium has established its role in 
obstetrics as it is an essential element for the development of the fetus. 
Magnesium deficiency may be associated with preeclampsia and premature 
birth and possibly low birth weight. Studies have found that magnesium 
deficiency during pregnancy significantly increases neonatal mortality and 
morbidity. Earlier studies conducted in developed countries have shown that 
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proper magnesium intake during pregnancy significantly reduces the cases of 
hospitalization of pregnant women, premature labor, intrauterine growth 
retardation and frequent targeting of the newborn to the intensive care unit. In 
addition, the results show a significant impact on fetal and maternal morbidity 
both before and after birth. Positive correlation between magnesium intake in 
the first trimester of pregnancy with the birth weight is documented. However, 
magnesium supplements use during the second and third trimesters do not 
have any effect about the pregnancy outcome (Pathak et al. 2004). Recent 
studies show that the magnesium has neuroprotective effect on the infants 
when the pregnant woman was treated for preterm delivery or preeclampsia 
with magnesium sulfate. Additionally, the researchers found that the incidence 
of cerebral palsy for the same infants is reduced (Cunningham et al. 2014). 
 
4.  Omega-3 fatty acids 
Omega-3 fatty acids are essential for the healty diet. Appropriate 
intake of omega-3 fatty acids is very important during pregnancy. They are 
fundamental components of the fetus' brain and retina. Omega-3 fatty acids 
may also play a role in determining the duration of pregnancy and in 
preventing perinatal depression. The most biologically active forms of omega-
3 fatty acids are docosahexaenoic acid (DHA) and eicosapentaenoic acid 
(EPA), which are derived predominantly from marine sources such as shellfish 
and algae (Coletta et al. 2010). Omega-3 is transferred from the mother to the 
fetus during pregnancy and from the mother to the infant after delivery through 
breastfeeding (Browne et al. 2006). The omega-3 fatty acids are essential 
nutrients and one of their important roles is the provision of 22 carbons  and 6 
double bonds known as DHA for the growth and function of nerve tissue. 
Insufficient intake of fatty acids-3 reduces DHA and increases omega-6 fatty 
acids in the brain. The decrease in DHA in the developing brain leads to 
deficiencies in neurogenesis, the metabolism of neurotransmitters, and altered 
visual function in animals. Western diets are low in omega-3 fatty acids, 
including the 18 carbons carbon-3 alpha-linolenic acids, mainly found in 
vegetable oils, and DHA, which is mostly found in fish. The state of DHA in 
the newborn and the infant depends on the maternal intake of DHA and varies 
widely. Epidemiological studies associate low DHA to mother with an 
increased risk of poor development of the nervous system. Intervention studies 
have shown that improving maternal nutrition with DHA reduces the risk of 
visual and neural development defects of the neonate and infant. There is 
sufficient evidence to conclude that the maternal diet rich of fatty acids is 
important for the transfer of DHA to the baby before and after birth, with short 
and long-term effects on neuronal function. However, genetic variations in the 
genes encoding fatty acid desaturases also influence the essential metabolism 
of fatty acids and may increase the requirements in some individuals. It is 
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important to include omega-3 fatty acids, for brain development of the fetus 
and the optimization of omega-3 and omega-6 fatty acids during pregnancy 
and lactation, as well as the fatty acids nutrients for intravenous and formula-
feed neonates (Innis 2008). The placenta regulates the nutritional, 
immunological and endocrine system of the fetus. The importance of fatty 
acids known to have immunomodulatory effects through the production of 
eicosanoids may end during pregnancy. Its complex metabolism varies from 
the deposition in maternal tissues at the beginning of pregnancy to the release 
during the last stage of pregnancy, to meet the fetal requirements. Previous 
attempts to modify the feeding of the pregnant woman and, therefore, the 
nutritional and immunological environment of the fetus are focused on the 
addition of long-chain polyunsaturated fatty acids (PUFA), fish oil and 
probiotic bacteria. Its synergistic effects suggest the need to look at the general 
diet (Kaplas et al. 2007). Depression during pregnancy affects both the mother 
and the child. The omega-3 PUFA with a possible antidepressant effect and 
lack of teratogenicity for the fetus, seem to be a beneficial alternative for the 
treatment (Chiu et al. 2003). 
 
5.  Probiotics 
The gastrointestinal tract acts as a barrier against potentially harmful 
antigens from microorganisms that may come from the food. The adequate 
physiological immune response in the gastrointestinal tract depends on the 
localization and the condition of the intestinal microflora. A new therapeutic 
approach in this area has been applied and it relies on the introduction of 
beneficial micro flora to the body designated as probiotics. A possible 
mechanism of probiotic therapy is the promotion of a non-immunological 
intestinal protective barrier, which includes normalizing the increased 
intestinal permeability and altered intestinal microecology. Another possible 
mechanism of probiotic therapy is to improve the immunological barrier of 
the intestine, in particular by intestinal immunoglobulin A responses and to 
alleviate intestinal inflammatory reactions that produce intestinal stabilizing 
effects. Many probiotic effects are mediated by immune regulation, in 
particular by controlling the balance of proinflammatory and anti-
inflammatory cytokines (Isolauri et al. 2001; Lukova et al. 2018). Interaction 
between hereditary factors and environmental factors appears to affect every 
stage of development from conception to the early postnatal period with 
potential long-term effects on the health of children and adults. During 
pregnancy, the immune and metabolic functions of the fetus depend on the 
mother. In addition, improving these functions seems to start in the uterus and 
is sensitive to the diet. Microbial life in the intestinal tract develops a number 
of physiological roles in the human body that affect both metabolic and 
immune functions, especially in early neonatal life and possibly even in the 
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womb. The transmission of bacteria from the mother to the newborn by direct 
contact with the mother's microbe at birth and breastfeeding during lactation 
period also appears to affect colon colonization with potential health 
consequences (Sanz 2011). Complications of pregnancy are associated with 
adverse outcomes for mother and baby in the short and long term. The 
probiotic supplements can help regulate the unbalanced microflora 
composition observed in obesity and diabetes (Arango et al. 2015). The 
prevalence of atopic diseases is increasing throughout the Western world, and 
primary prevention is needed to reverse this trend. The role of breastfeeding, 
the best source of nutrition for babies, in the protection against atopic disease 
remains elusive. The use of probiotics in pregnant and nursing women has 
been shown to increase the immunoprotective potential of breast milk as 
assessed by the amount of anti-inflammatory β2 (TGF-β2) growth factor in 
milk (Rautava et al. 2002). Mammary glands  can be affected by several 
factors, such as birth, breastfeeding, mother's lifestyle, health status, and diet. 
Numerous studies have shown a variety of positive effects from the use of 
probiotics during pregnancy and breastfeeding for the mother and the newborn 
(Treven et al. 2015). Lactic acid bacteria and bifidobacteria are increasingly 
being applied to pregnant women and infants with the intention of improving 
health. Although these organisms have a long record for safe use, it is 
important to identify all adverse effects in potentially vulnerable populations 
(Allen et al. 2010). Supplementation with probiotics during pregnancy has the 
potential to affect the immune parameters of the fetus as well as 
immunomodulatory factors in breast milk (Prescott et al. 2008). 
 
6.  Others 
6.1.  Iodine supplementation 
Maternal iodine is necessary for the normal development of the child’s 
brain during fetal and early postnatal life. For that reason, maternal iodine 
requirements increase during pregnancy and breastfeeding. Iodine 
requirements are 250-300 g/day during pregnancy, 225-350 g/day during 
breastfeeding, and 90 g/day during the neonatal period. It is observed that there 
is increased requirement for maternal iodine due to the transfer of thyroxine 
(T4) and iodide from mother to fetus during pregnancy and loss of iodide in 
breast milk during breastfeeding. These however are necessary to ensure 
normal brain development and to prevent mental retardation in the child. The 
requirement for iodine increases during pregnancy due to (Delange 2004):  
- increased requirement for T4 to maintain normal  generalmetabolism 
in the mother;  
-  the transfer of T4 and iodide from the mother to the fetus; 
-  increased iodide loss through the kidneys due to increased renal 
clearance of iodide; 
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The main change in thyroid function associated with pregnancy is the 
requirement for increased thyroid hormone production, which depends 
directly on the adequate availability of dietary iodine and the integrity of the 
glandular mechanism. Physiological adaptation occurs when iodine intake is 
adequate, and this is replaced by pathological changes when iodine deficiency 
occurs. Consequently, pregnancy typically acts as a revealer of major iodine 
restriction. Iodine deficiency (ID) has important consequences for both the 
mother and the fetus, resulting in permanent glandular stimulation, 
hypothyroxinemia and goitrogenesis. Furthermore, since severe identification 
may be associated with impairment of the psycho-neuro-intellectual outcome 
in offspring as the mother and offspring are exposed to ID during pregnancy 
(and postnatal period). Since ID still prevails today in several European 
countries - it is proposed to add iodine supplements to pregnant and nursing 
women in the early 1990s (Glinoer 2004). The fetus is completely dependent 
at the beginning of pregnancy from maternal thyroxine for normal brain 
development. Adequate maternal iodine delivery during pregnancy is essential 
for the production of thyroxine in the mother and later for thyroid function in 
the fetus. If iodine failure results in insufficient thyroid hormone production 
and hypothyroidism during pregnancy, irreversible damage to the fetal brain 
may occur. The American Thyroid Association recommends that women 
receive 150 μg iodine supplements daily during pregnancy and lactation and 
that all prenatal vitamin-mineral preparations contain 150 μg of iodine (Becker 
et al. 2006). 
 
6.2.  Calcium supplementation 
Calcium homeostasis is maintained by the parathyroid hormone (PTH) 
and 1,25-dihydroxyvitamin D, (1,25 [OH] 2D3). About 50 percent of serum 
calcium is bound to proteins (mostly albumin), 10 percent in the form of 
anionic complexes, and 40% circulates freely as ionized calcium. During 
pregnancy there is an active transfer of maternal calcium to the fetus. Before 
birth, the fetus needs 25 to 30 g of calcium for bone mineralization. Total 
serum calcium during pregnancy is 8 per cent below the level after delivery . 
The upper limit of normal is 9.5 mg per milliliter. This reduction in total serum 
calcium is due to physiological hypoalbuminemia, which is secondary to the 
normal widening of the intravascular volume observed at the beginning of 
pregnancy. However, the ionized calcium levels remain unchanged during 
pregnancy. Serum levels of calcitonin are higher during pregnancy and 
postpartum than in non-pregnancy controls. In 20 per cent of patients, the 
values exceed the normal range of pregnancy (Gabbe et al. 2002). Calcium 
metabolism during pregnancy is a complex process involving calcium, 
phosphorus, vitamin D, parathyroid hormone (PTH) and calcitonin (CT). The 
absorption of calcium is increased during pregnancy and probably increased 
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storage in the maternal skeleton. Adequate amounts are provided by the 
current recommended dietary allowance of 1200 mg daily, which can easily 
be satisfied with natural foods, especially milk. If additional calcium is given, 
it is probably advisable to use nonphosphate salt. Some evidence suggests that 
excessive phosphate intake may be associated with leg cramps during 
pregnancy (Pitkin 1975). Preeclampsia and eclampsia are common causes of 
serious morbidity and death. Calcium supplementation can reduce the risk of 
preeclampsia and can help prevent premature birth. Calcium supplementation 
(≥1 g/day) is associated with a significant reduction in the risk of 
preeclampsia, especially in women with low calcium levels. It also reduces 
premature birth and the occurrence of a combined outcome of "maternal death 
or serious morbidity". The World Health Organization recommends calcium 
1.5 g to 2 g per day for pregnant women with low dietary calcium intake 
(Hofmeyr et al. 2014). During pregnancy there are considerable changes in 
maternal calcium metabolism and serum levels of vitamin D due to the fetal 
bone mineral accretion. During the last trimester the fetus receives roughly 25-
30 g of calcium. Additional quantities of the microelement may be acquired 
through increased intestinal absorption from calcium rich foods, increased 
renal conservation and increased bone mobilization (Hod et al. 2008). 
 
6.3  Vitamin D supplementation 
The initial studies on the importance of vitamin D have been limited 
to its role in regulating calcium and phosphate levels, and its involvement in 
the pathogenesis of rickets. Further studies however have found the presence 
of vitamin D receptors linked to chromosomes in almost every cell and tissue 
in the body, thus leading to its important effects on different organs. These 
effects and the fact that vitamin D is made in the skin by ultraviolet-B (UVB) 
radiation followed by a thermal process, and that the active vitamin D 
circulates in the blood created a new understanding of vitamin D as a hormone. 
Vitamin D is crucial during pregnancy as the mother is the sole source of 
vitamin D substrate for the developing fetus. While vitamin D status during 
pregnancy varies worldwide as it depends on the degree of sunlight exposure, 
degree of skin pigmentation, latitude, lifestyle, body mass index and the intake 
of oral vitamin D supplements, it is clear that women with darker pigmentation 
and limited sunlight exposure are at greatest risk for vitamin D deficiency. It 
is established that if a woman is deficient during her pregnancy, her fetus also 
will be deficient during gestation ( Delange 2004). Vitamin D is known to be 
involved in skeletal homeostasis during pregnancy, and severe vitamin D 
deficiency may lead to neonatal seizures in neonates with profound 
hypocalcemia (Hollis et al. 2011). During pregnancy and lactation, the mother 
requires significant amounts of calcium to pass on to the developing fetus and 
suckling neonate, respectively. Given that adult calcium and bone metabolism 
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depend on vitamin D sufficiency,  it would seem to be especially critical 
during pregnancy and lactation. The vitamin D–deficient or insufficient 
neonate is at risk of problems, including hypocalcemia and rickets. Due to 
poor penetrance of vitamin D and 25-hydroxyvitamin D [25(OH)D] into milk, 
exclusively breastfed infants are at higher risk of vitamin D deficiency than 
are formula-fed infants (Kovacs 2008). The main function of vitamin D is to 
maintain calcium and phosphate homeostasis so that their serum levels remain 
optimal for normal neuromuscular function and bone mineralization. Other 
than that, however it has been established that vitamin D metabolites have 
additional physiological and pharmacological effects. Vitamin D undergoes 
biosynthesis from 7-dehydrocholesterol in the epidermis under the influence 
of ultraviolet radiation but it can also be acquired through proper diet. It is 
subsequently transported to the liver where it undergoes hydroxylation which 
results in its inactive form 25-hydroxyvitamin D. In the kidneys the active 
form of vitamin D - 1,25-dihydroxyvitamin D is formed through further 
hydroxylation. The active form increases intestinal calcium absorption, 
decreases renal excretion and under the influence of the parathyroid hormone 
activates calcium bone mobilization. Significant changes in maternal vitamin 
D and calcium metabolism occur during pregnancy to provide the calcium 
needed for fetal bone mineral accretion (Hod et al. 2008).  
 
II.  Food supplements use during pregnancy: risks 
Food supplements represent concentrated sources of nutrients like 
minerals, vitamins, amino acids, omega fatty acids and/or other substances 
(EFSA, Crişan, 2012). These products are intended only to enrich the diet. 
They are not medicinal products and should not pretend for health claims 
(EFSA). The food supplement market has continuously grown in the last ten 
years not only in the European Union but also all over the World (Crişan 2012; 
Strano-Rossi et al. 2015). In the European Union, food supplements are 
regulated as foods (EFSA). The current legislation of the European Union is 
designed to protect consumers from misleading and false claims (Nocella and 
Kennedy 2012) but at the same time there is not obligatory analytical control 
(Ivanova 2017). The lack of obligatory quality control has led to many cases 
of undeclared substances in food supplements (Neves and Caldas 2017).  
Recent studies have declared results that dietary supplements might contain 
undeclared substances in levels that could represent potential health risks 
(Venugopal et al. 1996; Ernst 2002; Martello et al. 2007; Ancuceanu et al. 
2013; Haneef et al. 2013; Venhuis et al. 2014; Gaudiano et al. 2016; da Justa 
et al 2017; Petkova-Gueorguieva et al. 2018). Data from modern studies show 
that customers believe that food supplements are safe products and even safer 
than conventional drugs (Petkova - Gueorguieva et al. 2018) . In the last 
decade, many patients believe that conventional drugs should be avoided 
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because they “might” cause autism (vaccines) (Peteva et al. 2016), toxic 
effects or some serious side effects. The conventional drugs are essential for 
the quality of humans’ life. These products have prolonged and imploved the 
quality of humans’ life. The medicinal products are used for the treatment of 
different pathologies and they have predictable side effects. The quality 
control for medicinal products is obligatory all over the world and it is applied 
throughout all processing stages - from the drug substance to the finished 
product. Many analytical techniques like High-performance liquid 
chromatography (HPLC) and Gas chromatography are involved in the quality 
control of drugs. There is also an obligatory post-marketing control. Most 
customers consider that food supplements are pharmaceutical products with 
high quality ( Petkova - Gueorguieva et al. 2018). The analytical control of 
food supplements is essential for customer safety. It is very important the 
quality control to be obligatory and to be applied throughout all processing 
stages - from the raw material to the finished product (Petkova-Gueorguieva 
et al 2018; Sanzini 2011). Unfortunately, the analytical control for these 
products is not obligatory (Ivanova 2017). Most of the food supplements are 
either poorly monitored or not even monitored at all (Ekor 2014) . The 
adequate supply of nutrients is probably one of the most important factors 
affecting pregnancy outcome (Kamber et al. 2001; Halsted 2003). Poor intakes 
of iron, folic acid, magnesium, calcium and other nutrients induce a poor 
maternal status and could be associated with some serious problems (Ekor 
2014, Martínez-Sanz et al. 2017). It is important for the pregnant woman to 
have an adequate diet but also it is important the diet to be enriched with food 
supplements. It is important the food supplements to be provided by reliable 
manufacturers, who have a GMP certificate, traditions in the manufacturing 
and quality control systems. 
 
Conclusion 
     Pregnancy is a physiological condition, associated with dynamic 
processes and many physiologic adjustments that affect the metabolism of all 
nutrients. The main purpose of these adjustments is to support the fetal growth 
and the maternal homeostasis. Poor intake of some nutrients is associated with 
serious health consequences during pregnancy. The diet of pregnant woman is 
important to be enriched with food supplements containing some important 
nutrients for both the maternal and fetal organism. It is important to note that 
food supplements are not pharmaceutical products. The quality of the food 
supplements is not supposed to be the same as that of the conventional drugs. 
In the European Union and in the most part of the World these products are 
regulated as “foods”. There is not obligatory analytical control (quality and 
quantity) for food supplements. This is associated with many cases of poor 
quality of food supplements and that could cause some negative health 
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consequences. It would be very dangerous for a pregnant woman to intake 
products with poor quality. It is important the food supplements to be provided 
by reliable manufacturers, who have a GMP certificate, traditions in the 
manufacturing and reliable quality control systems. 
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